A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
Journal
Haematologica
Journal Volume
105
Journal Issue
7
Pages
E349-E354
Date Issued
2020
Author(s)
Tsai H.-J.
Tai J.J.
Chen L.-T.
Wang T.-E.
Yu F.-J.
Hsiao C.-F.
Yeh H.-J.
Ko C.-W.
Chen M.-J.
Lo G.-H.
Hsu P.-I.
Chang C.-S.
Hwang W.-S.
Chuang S.-S.
Lee H.-W.
Chiu C.-F.
Wang W.-M.
Hsieh C.-Y.
Liu T.-W.
Lin J.-T.
SDGs
Other Subjects
B cell lymphoma/leukemia 10; immunoglobulin enhancer binding protein; antiinfective agent; adult; antibiotic therapy; cancer staging; cell proliferation; diffuse large B cell lymphoma; echography; endoscopic ultrasonography; female; follow up; histology; human; human tissue; immunohistochemistry; Letter; major clinical study; male; marginal zone lymphoma; multicenter study; overall survival; prospective study; recurrence free survival; stomach biopsy; stomach lymphoma; stomach mucosa; treatment response; clinical trial; diffuse large B cell lymphoma; lymphoid tissue; marginal zone lymphoma; mucosa; Anti-Bacterial Agents; Humans; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Mucous Membrane; Prospective Studies
Publisher
Ferrata Storti Foundation
Type
letter